Mariner LLC Raises Position in Leidos Holdings, Inc. $LDOS

Mariner LLC increased its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 2.7% during the fourth quarter, HoldingsChannel reports. The firm owned 907,952 shares of the aerospace company’s stock after acquiring an additional 23,637 shares during the period. Mariner LLC’s holdings in Leidos were worth $163,803,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of LDOS. Norges Bank bought a new stake in shares of Leidos in the fourth quarter valued at $318,839,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Leidos during the 3rd quarter worth $242,464,000. Alliancebernstein L.P. increased its holdings in Leidos by 64.4% in the 2nd quarter. Alliancebernstein L.P. now owns 1,529,261 shares of the aerospace company’s stock worth $241,256,000 after acquiring an additional 598,974 shares during the last quarter. M&T Bank Corp raised its stake in Leidos by 2,924.4% in the 4th quarter. M&T Bank Corp now owns 405,181 shares of the aerospace company’s stock valued at $73,095,000 after acquiring an additional 391,784 shares during the period. Finally, Wedge Capital Management L L P NC raised its stake in Leidos by 663.3% in the 4th quarter. Wedge Capital Management L L P NC now owns 355,824 shares of the aerospace company’s stock valued at $64,191,000 after acquiring an additional 309,206 shares during the period. 76.12% of the stock is owned by hedge funds and other institutional investors.

Leidos Price Performance

Shares of Leidos stock opened at $122.05 on Monday. The firm has a market capitalization of $15.35 billion, a PE ratio of 11.18, a price-to-earnings-growth ratio of 1.55 and a beta of 0.51. The company has a current ratio of 1.40, a quick ratio of 1.29 and a debt-to-equity ratio of 1.19. Leidos Holdings, Inc. has a 12 month low of $121.20 and a 12 month high of $205.77. The business’s 50-day moving average price is $137.96 and its 200-day moving average price is $166.17.

Leidos (NYSE:LDOS) last issued its earnings results on Tuesday, May 5th. The aerospace company reported $3.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.25. Leidos had a return on equity of 31.92% and a net margin of 8.15%.The business had revenue of $4.40 billion during the quarter, compared to analyst estimates of $4.28 billion. During the same quarter in the prior year, the firm earned $2.97 earnings per share. Leidos’s revenue for the quarter was up 3.7% on a year-over-year basis. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. Sell-side analysts forecast that Leidos Holdings, Inc. will post 12.25 EPS for the current fiscal year.

Leidos Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be issued a dividend of $0.43 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. Leidos’s dividend payout ratio (DPR) is currently 15.75%.

Insider Buying and Selling at Leidos

In related news, Director Gary Stephen May sold 1,484 shares of Leidos stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $132.75, for a total value of $197,001.00. Following the transaction, the director owned 10,137 shares in the company, valued at $1,345,686.75. This trade represents a 12.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Elizabeth A. Porter sold 2,000 shares of the business’s stock in a transaction on Tuesday, April 7th. The stock was sold at an average price of $158.78, for a total transaction of $317,560.00. Following the completion of the sale, the insider directly owned 49,476 shares of the company’s stock, valued at $7,855,799.28. This represents a 3.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.77% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Robert W. Baird reduced their price objective on shares of Leidos from $215.00 to $195.00 and set a “neutral” rating for the company in a research note on Wednesday, February 18th. Wells Fargo & Company initiated coverage on Leidos in a research report on Wednesday, April 1st. They set an “equal weight” rating and a $165.00 target price on the stock. Stifel Nicolaus cut their price target on Leidos from $205.00 to $193.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Royal Bank Of Canada decreased their price objective on Leidos from $215.00 to $180.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 6th. Finally, Wall Street Zen upgraded Leidos from a “hold” rating to a “buy” rating in a research note on Sunday. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $187.50.

Leidos Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.